text:
Fastest Pitchers in Baseball History
They could throw the ball over 100 miles per hour. With ease.
Few positions in professional sports render an athlete more helpless than standing in the batter's box and facing down a pitcher who can zip the ball past you at over 100 miles per hour.
Fortunately for major league hitters, those kinds of pitches and the pitchers that throw them don't come around very often. Only a few players have ever been able to throw the ball at that speed.
These are the fastest pitchers in baseball history, based on miles per hour of their fastest pitch.
30. Tim Lincecum
Top speed: 101 miles per hour (2007)
Throws: Right
Career: 10 seasons (2007-16)
Teams: San Francisco Giants (2007-15), Los Angeles Angels (2016)
Career highlights: Three-time World Series champion (2010, 2012, 2014), four-time MLB All-Star (2008-11), two-time NL Cy Young Award winner (2008, 2009)
Bottom Line: Tim Lincecum
Several dozen pitchers tied for reaching 101 miles per hour, so we just chose one to represent all of them. The "chosen one" got the call because of his rare place in baseball history.
Checking in at just 5-foot-11 and 175 pounds, Tim Lincecum was nicknamed "The Freak" because of his athletic ability and ability to contort his body to throw a baseball at the speed he did.
He also was a two-time NL Cy Young Award winner, won three World Series championships and threw two no-hitters.
29. Rob Dibble
Top speed: 101.5 miles per hour (1992)
Career: 8 seasons (1988-95)
Teams: Cincinnati Reds (1988-93), Chicago White Sox (1995), Milwaukee Brewers (1995)
Career highlights: World Series champion (1990), NLSC MVP (1990), two-time MLB All-Star (1990, 1991)
Bottom Line: Rob Dibble
Baseball fans from the early 1990s remember Rob Dibble well. He helped define the "forgotten era" of baseball because of his intimidating presence on the mound and by how darn hard he threw the ball.
Dibble was one of the "Nasty Boys" for the Reds when they won the World Series in 1990. That was the nickname they gave the pitching staff on the way to a sweep of the powerful Oakland A's to win the championship.
Dibble also loved to throw down — with other teams and with his own manager on one occasion.
28. Nathan Eovaldi
Career: 11 seasons (2011-present)
Teams: Los Angeles Dodgers (2011-12), Miami Marlins (2012-14), New York Yankees (2015-16), Tampa Bay Rays (2018), Boston Red Sox (2018-present)
Career highlights: World Series champion (2018), MLB All-Star (2021)
Bottom Line: Nathan Eovaldi
There must be something in the water at Alvin (Texas) High School. Nathan Eovaldi is one of two all-time flamethrowers to come out of the school alongside GOAT pitcher Nolan Ryan.
Eovaldi pitched eight seasons in the majors before his career really took off, winning a World Series with the Boston Red Sox in 2018, then making his first All-Star appearance in 2021.
27. Emmanuel Clase
Career: 2 seasons (2019, 2021-present)
Teams: Texas Rangers (2019), Cleveland Indians/Guardians (2021-present)
Career highlights: None
Bottom Line: Emmanuel Clase
Emmanuel Clase is one of the youngest players on this list at just 23 years old but already has some stink on his name thanks to an 80-game suspension for using anabolic steroids in 2020.
Clase didn't even have to serve the suspension because he didn't play for the Cleveland Indians at all during the 2020 season and due to the shortened season/pandemic — which seems like a weird way to deal with a positive PED test.
Clase bounced back in 2021 and was named AL Reliever of the Month in August after converting all six of his save opportunities.
21. Brad Lidge (Tie)
Teams: Houston Astros (2002-07), Philadelphia Phillies (2008-11), Washington Nationals (2012)
Career highlights: World Series champion (2008), two-time MLB All-Star (2005, 2008), NL Comeback Player of the Year (2008)
Bottom Line: Brad Lidge
Notre Dame product and former Big East Player of the Year Brad Lidge was one of the more dominant relief pitchers in the majors during most of his decade-long career.
The pitch that Lidge could really turn up the heat on was his four-seam fastball, and the two-time All-Star used it to help the Philadelphia Phillies record the final out of the 2008 World Series against the Tampa Bay Rays.
21. Rob Nenn (Tie)
Career: 10 seasons (1993-2002)
Teams: Texas Rangers (1993), Florida Marlins (1993-97), San Francisco Giants (1998-2002)
Career highlights: World Series champion (1997), three-time MLB All-Star (1998, 1999, 2002)
Bottom Line: Rob Nenn
Robb Nenn was a dominant relief pitcher in the late 1990s and early 2000s, helping lead the Florida Marlins to a World Series championship in 1997. The team didn't lose a game in which Nenn made an appearance.
Nenn was part of the Marlins' fire sale following the 1997 championship and made three All-Star appearances with the San Francisco Giants following that. Nenn had 40 saves in his first season as the Giant's full-time closer and led the National League with 45 saves in 2002.
He officially retired in 2005 as the franchise's career saves leader.
21. Matt Lindstrom (Tie)
Teams: Florida Marlins (2007-09), Houston Astros (2010), Colorado Rockies (2011), Baltimore Orioles (2012), Arizona Diamondbacks (2012), Chicago White Sox (2013-14)
Bottom Line: Matt Lindstrom
Matt Lindstrom played eight seasons in the majors but never lasted more than three seasons for the six teams he played for. Lindstrom had his best season with the Houston Astros in 2010, picking up 23 saves.
Lindstrom is also part of an interesting piece of sports trivia. He threw the last in-game pitch at Shea Stadium in 2008, earning a save for the Florida Marlins against the New York Mets.
21. Randy Johnson (Tie)
Throws: Left
Teams: Montreal Expos (1988-89), Seattle Mariners (1989-98), Houston Astros (1998), Arizona Diamondbacks (1999-2004, 2007-08), New York Yankees (2005-06), San Francisco Giants (2009)
Career highlights: World Series champion (2001), five-time Cy Young Award (1995, 1999-2002), World Series MVP (2001), 10-time All-Star (1990, 1993-95, 1997, 1999-2002, 2004), Triple Crown (2002), MLB wins leader (2002), four-time ERA leader (1995. 1999, 2001, 2002), nine-time MLB strikeouts leader (1992-95, 1999-2002, 2004)
Bottom Line: Randy Johnson
Five-time Cy Young Award winner Randy Johnson, at 6-foot-10, had a career record of 303-166 and was one of the most intimidating pitchers of all time.
Batters who faced Johnson in his prime routinely talked about their fear for their own physical safety at the plate because of his size and the speed at which he threw the ball.
This fear was best (and most comically) evidenced by John Kruk's reaction when Johnson threw a fastball over Kruk's head during the 1993 All-Star Game.
21. Bobby Jenks (Tie)
Teams: Chicago White Sox (2005-10), Boston Red Sox (2011)
Career highlights: World Series champion (2005), two-time MLB All-Star (2006, 2007)
Bottom Line: Bobby Jenks
Bobby Jenks was called up to the majors with the Chicago White Sox in July 2005 and became a key part of their run to the World Series championship.
Jenks pitched in all four games of the World Series that year and earned the save in the series-clinching Game 4. In fact, Jenks and Adam Wainwright are the only two rookies in MLB history to earn a save in the final game of the World Series.
Jenks set the MLB record with 41 consecutive retired batters in 2007. His career was cut short following a botched back surgery in 2011. Jenks eventually sued the hospital and the doctor who performed the surgery and received a $5.1 million settlement.
21. Armando Benitez (Tie)
Teams: Baltimore Orioles (1994-98), New York Mets (1999-2003), New York Yankees (2003), Seattle Mariners (2003), Florida Marlins (2004, 2007), San Francisco Giants (2005-07), Toronto Blue Jays (2008)
Career highlights: Two-time MLB All-Star (2003, 2004)
Bottom Line: Armando Benitez
Armando Benitez's postseason struggles with the Baltimore Orioles in the 1990s weren't exactly all his fault. He was the pitcher who gave up the infamous "Jeffrey Maier home run" against the New York Yankees in Game 1 of the 1996 ALCS. Maier, a 12-year-old Yankees fan, reached onto the field of play and caught the ball as it was about to drop into the glove of outfielder Tony Tarasco.
Benitez still had a lengthy career. He played 15 seasons for seven teams, led the National League in saves in 2004 and was a two-time All-Star.
18. Joe Kelly (Tie)
Teams: St. Louis Cardinals (2012-14), Boston Red Sox (2014-18), Los Angeles Dodgers (2019-present)
Career highlights: Two-time World Series champion (2018, 2020)
Bottom Line: Joe Kelly
The son of a former NFL linebacker, Joe Kelly has made his name over the last five years thanks to his blazing arm speed, quirky off-field persona and winning two World Series championships with two different franchises.
Despite all of Kelly's accomplishments, he's better known for running his mouth than his blazing fastball and accomplishments on the mound. He told the media he would win the American League Cy Young Award in 2015, then proceeded to go 10-6 with a 4.25 ERA and lead AL pitches in errors.
18. Brian Wilson (Tie)
Teams: San Francisco Giants (2006-12), Los Angeles Dodgers (2013-14)
Bottom Line: Brian Wilson
Brian Wilson was one of the more notable players in the majors in the late 2000s and early 2010s as the closer for the San Francisco Giants thanks to his fiery persona and trademark jet-black beard.
Wilson made three All-Star appearances in a four-season stretch from 2008 to 2011, and was at his best in 2010, when he had a 1.81 ERA, led the National League with 48 saves, and picked up the save in the World Series-clinching win over the Texas Rangers.
18. Jacob deGrom (Tie)
Career: 8 seasons (2014-present)
Teams: New York Mets
Career highlights: Two-time NL Cy Young Award winner (2018, 2019), four-time MLB All-Star (2015, 2018, 2019, 2021), NL Rookie of the Year (2014)
Bottom Line: Jacob deGrom
Jacob deGrom has been one of the most dominant pitchers in the majors over the last decade, leading the National League in strikeouts twice, ERA once and picking up two Cy Young Awards in 2018 and 2019. DeGrom was also the NL Rookie of the Year in 2014.
Incredibly, he's done all of that while playing the entirety of his career with the New York Mets.
17. Brusdar Graterol
Teams: Minnesota Twins (2019), Los Angeles Dodgers (2020-present)
Career highlights: World Series champion (2020)
Bottom Line: Brusdar Graterol
Brusdar Graterol was signed as an international free agent by the Minnesota Twins at just 16 years old, made his professional debut at 17, and underwent Tommy John surgery and missed a full season at 18.
After his return from surgery, Graterol shot up through the minor leagues and was called up to the Twins in September 2019, when he pitched 9.2 innings and struck out 10 batters.
Graterol was traded to the Los Angeles Dodgers in February 2020 and helped the franchise to a World Series championship in 2020 and back to the NLCS in 2021.
16. Jonathan Broxton
Teams: Los Angeles Dodgers (2005-11), Kansas City Royals (2012), Cincinnati Reds (2012-14), Milwaukee Brewers (2014-15), St. Louis Cardinals (2015-17)
Bottom Line: Jonathan Broxton
By the time Jonathan Broxton was a high school senior at Burke County High School in Waynesboro, Georgia, he was 6-foot-4 and 250 pounds and had pro baseball scouts salivating.
Broxton was selected by the Los Angeles Dodgers in the second round of the 2020 MLB draft and made his major league debut in 2005, striking out the first batter he faced — St. Louis Cardinals slugger Albert Pujols.
Broxton had two great seasons as the full-time closer for the Dodgers, making back-to-back All-Star appearances in 2009 and 2010.
15. Kelvin Herrera
Teams: Kansas City Royals (2011-18), Washington Nationals (2018), Chicago White Sox (2019-20)
Bottom Line: Kelvin Herrera
Kelvin Herrera is one of the most respected middle relief pitchers of all time. And the trio of Herrera, Greg Holland and Wade Davis was a key component of the back-to-back World Series teams for the Kansas City Royals in 2014 and 2015, winning the title in 2015.
Herrera was so well-respected in his role with the Royals that he made back-to-back All-Star appearances in 2015 and 2016. He eventually became the Royals' full-time closer in 2017 and retired from professional baseball in 2021.
14. Yordano Ventura
Teams: Kansas City Royals
Bottom Line: Yordano Ventura
Yordano Ventura was a shooting star for the Kansas City Royals in the mid-2010s, helping lead the team to back-to-back World Series appearances in 2014 and 2015 and winning the World Series championship in 2015.
Ventura died on Jan. 22, 2017, at just 25 years old in a car crash in his native Dominican Republic and had $20 million left on his contract with the Royals.
Ventura was one of two major leaguers in the Dominican Republic to die in a car crash that day, along with Andy Marte.
11. Mark Wohlers (Tie)
Teams: Atlanta Braves (1991-99), Cincinnati Reds (2000-01), New York Yankees (2001), Cleveland Indians (2002)
Bottom Line: Mark Wohlers
Massachusetts native Mark Wohlers turned his back on a baseball scholarship from the University of Maine to turn pro, and became a key member of the Atlanta Braves on their great teams in the 1990s.
Less than one month after turning pro in 1991, Wohlers combined with Kent Mercker and Alejandro Pena for a no-hitter against the San Diego Padres at Fulton County Stadium. Four years later, Wohlers was the Braves' full-time relief pitcher and closed out a World Series-clinching Game 6 against the Cleveland Indians.
11. Bobby Parnell (Tie)
Teams: New York Mets (2008-15), Detroit Tigers (2016)
Career highlights: NLCS champion (2015)
Bottom Line: Bobby Parnell
Bobby Parnell broke into the majors with the New York Mets at 23 years old and had some decent seasons with the team, most notably with a career-high 22 saves in 2013.
Parnell didn't begin pitching until his freshman season at Charleston Southern and struggled with his control. The problem didn't fix itself when he finally made it to the majors.
But Parnell worked his way up from middle relief to be the closer for the Mets in 2013. Then an injury shut him down for the season in July. In 2014, he was named the closer for the Mets again and blew a save in the season opener, when he also tore his ulnar collateral ligament and underwent Tommy John surgery and was out for the season.
By 2016, he was gone from the majors for good.
11. Goose Gossage (Tie)
Career: 22 seasons (1972-89, 1991-94)
Teams: Chicago White Sox (1972-76), Pittsburgh Pirates (1977), New York Yankees (1978-83, 1989), San Diego Padres (1984-87), Chicago Cubs (1988), San Francisco Giants (1989), Texas Rangers (1991), Oakland Athletics (1992-93), Seattle Mariners (1994)
Career highlights: World Series champion (1978), nine-time MLB All-Star (1975-78, 1980-82, 1984, 1985)
Bottom Line: Goose Gossage
Rich "Goose" Gossage is one of the most well-known relief pitchers of all time, most notably from his time with the New York Yankees and San Diego Padres, including when he won a World Series championship with the Yankees in 1978.
Gossage had straight flames coming out of his powerful right arm, topping out at 103 miles per hour on a pitch during that 1978 season. Gossage also made nine All-Star teams.
8. Henry Rodriguez (Tie)
Teams: Oakland Athletics (2009-10), Washington Nationals (2011-13), Chicago Cubs (2013), Miami Marlins (2014)
Bottom Line: Henry Rodriguez
Henry Rodriguez's arm strength helped him carve out a six-year career in the majors. His inability to effectively develop other pitches prevented him from staying longer.
Rodriguez's four-seam fastball was tough to hit, but the dropoff between his main pitch and his two other pitches — a curveball and changeup thrown in the low-to-mid 80s was pretty remarkable.
Rodriguez could never catch on as a full-time closer because he struggled so much with his control. He had a career walk rate of 5.6 per nine innings and led the National League in wild pitches in 2011 and in 2012 despite throwing only 21 innings.
8. Mauricio Cabrera (Tie)
Career: 1 season (2016)
Teams: Atlanta Braves
Bottom Line: Mauricio Cabrera
Mauricio Cabrera is another pitcher on this list who could throw a blazing four-seam fastball, but his inability to develop other pitches led to a strikingly short career in the majors.
Cabrera had a pretty impressive rookie season, making his short amount of time in the majors even more confounding. He went 5-1 with six saves and a 2.82 ERA in 2016. Cabrera and his brother, Alberto, both pitched in the majors.
8. Justin Verlander (Tie)
Teams: Detroit Tigers (2005-17), Houston Astros (2017-present)
Career highlights: World Series champion (2017), AL MVP (2011), eight-time MLB All-Star (2007, 2009-13, 2018, 2019), two-time AL Cy Young Award (2011, 2019), AL Triple Crown (2011), ALCS MVP (2017), AL Rookie of the Year (2006)
Bottom Line: Justin Verlander
Justin Verlander has been one of the best pitchers in the majors for almost two decades and can take his place among the greatest pitchers of all time. He is a surefire first-ballot Hall of Famer whether he ever pitches another game or not.
Verlander, who won a World Series championship with the Astros in 2017, was the American League Most Valuable Player in 2011, led the AL in strikeouts five times, led the majors in wins three times and threw three no-hitters.
7. Neftali Feliz
Career: 10 seasons (2009-17, 2021)
Teams: Texas Rangers (2009-15), Detroit Tigers(2015), Pittsburgh Pirates (2016), Milwaukee Brewers (2017), Kansas City Royals (2017), Philadelphia Phillies (2021), Los Angeles Dodgers (2021)
Career highlights: MLB All-Star (2010), AL Rookie of the Year (2010)
Bottom Line: Neftali Feliz
Neftali Feliz was only 21 years old when he made his MLB debut in 2010 and took the league by storm. He posted 38 saves that season and recorded the final three outs of the American League Championship Series to send the Texas Rangers to the World Series for the first time in franchise history.
Feliz also recorded a blazing,103.4 miles per hour pitch that season and was named American League Rookie of the Year.
He returned to the World Series with the Rangers in 2011 and gave up a crucial triple against the St. Louis Cardinals with the lead in Game 6 and the Rangers just a few outs from winning the series.
6. Joel Zumaya
Teams: Detroit Tigers
Bottom Line: Joel Zumaya
Hall of Fame catcher Ivan Rodriguez said no one he ever caught threw the ball harder than Joel Zumaya. The problem was, Zumaya was never able to develop an off-speed pitch, which is why his career only lasted five seasons.
Zumaya's inability to develop more than one pitch relegated him to middle relief and a role as setup man for his five seasons in the majors. He was very good during that time, but a string of injuries ultimately ended his career.
The first one was the most bizarre. That's when Zumaya sat out the 2006 American League Championship Series because he injured his wrist playing the video game "Guitar Hero."
5. Steve Dalkowski
Top speed: 105.0 miles per hour (unknown)
Teams: Minor leagues
Bottom Line: Steve Dalkowski
Steve Dalkowski is the only player to make this list who never actually pitched in the majors. But we could not have put together a list of the fastest pitchers of all time without including Dalkowski, even if his top miles per hour on a pitch is largely anecdotal.
Dalkowski was the inspiration for the character Ebby Calvin "Nuke" Laloosh in Ron Shelton's 1988 baseball film "Bull Durham" and was played by a young Tim Robbins.
Dalkowski, who died in 2020 at 80 years old, was written about perfectly by Sports Illustrated's Pat Jordan in an story titled "The Wildest Fastball Ever": "Inevitably, the stories outgrew the man, until it was no longer possible to distinguish fact from fiction. But, no matter how embellished, one fact always remained: Dalkowski struck out more batters and walked more batters per nine-inning game than any professional pitcher in baseball history."
In nine full minor league seasons, Dalkowski registered 1,396 strikeouts and 1,354 walks in 995 innings.
4. Jordan Hicks
Career: 3 seasons (2018-19, 2021)
Teams: St. Louis Cardinals
Bottom Line: Jordan Hicks
Jordan Hicks is another flamethrower who hails from the state of Texas. The Houston-area native turned his back on a college baseball career at Tulane to turn pro and was in the majors within two years.
Hicks got off to a blazing start in the majors, clocking in with an average velocity of 100.4 miles per hour in his MLB debut and hitting 105.1 miles per hour on a pitch less than one month later.
Hicks was out of baseball for almost two years after Tommy John surgery on his right elbow in June 2019, then he chose to sit out the 2020 season because of the pandemic.
He returned to the majors in 2021 and pitched in 10 games, striking out 10 and walking 10 in 10 innings.
3. Aroldis Chapman
Teams: Cincinnati Reds (2010-15), New York Yankees (2016, 2017-present), Chicago Cubs (2016)
Career highlights: World Series champion (2016), seven-time MLB All-Star (2012-15, 2018, 2019, 2021), AL Reliever of the Year (2019)
Bottom Line: Aroldis Chapman
Aroldis Chapman has the fastest recorded pitch on record in MLB history, when he turned a baseball into pure gas against Tony Gwynn Jr. on Sept. 24, 2010, reaching 105.1 miles per hour.
In one of the more amazing unknown stats in baseball history — and one you can feel free to use and impress your friends with — Chapman had all 77 of the fastest-clocked pitches in MLB in 2015.
None of that should take away from the fact MLB allowed him to continue to play and the United States allowed him to become a citizen after a sadistic act of domestic violence that should have landed him in prison for decades.
2. Bob Feller
Teams: Cleveland Indians
Career highlights: World Series champion (1948), Triple Crown (1940), eight-time All-Star (1938-41, 1946-48, 1950), six-time AL wins leader (1939-41, 1946-47, 1951), AL ERA leader (1940)
Bottom Line: Bob Feller
There's enough historical evidence for us to put Bob Feller at this spot, even if pitch-tracking in regards to speed was still in the stone ages in the 1940s. They used cartography or timed pitches against motorcycles, which is how we got this miles per hour number for Feller.
Feller, who died in 2010, missed three seasons in his prime serving in World War II from 1942 to 1944. He still threw three no-hitters in his career.
1. Nolan Ryan
Career: 27 seasons (1966, 1968-93)
Teams: New York Mets (1966, 1968-71), California Angels (1972-79), Houston Astros (1980-88), Texas Rangers (1989-93)
Career highlights: World Series champion (1969), eight-time All-Star (1972, 1973, 1975, 1977, 1979, 1981, 1985, 1989), 11-time MLB strikeout leader (1972-74, 1976-79, 1987-90), two-time NL leader (1981, 1987), MLB All-Century Team
Bottom Line: Nolan Ryan
Nolan Ryan was clocked at 101.5 miles per hour on the pitch in question. That number was being clocked 10 feet in front of the plate, which was how pitches were originally clocked for speed.
The math done on the speed of the pitch got us to 108.5 miles per hour. Ryan's fastball was fast enough to throw seven no-hitters over a 27-year career.
The legend of the Ryan Express started as a star pitcher for Alvin (Texas) High School. It wasn't uncommon for opposing coaches to hold batters in the dugout and take the out instead of stepping in the box against Ryan.


text:
J&J to Stop Selling Talc-Based Baby Powder in US
The company says the decline in demand for these products in North America has been "fueled by misinformation."
Linda Johnson
This Oct. 21, 2019, photo shows Johnson's Baby Aloe & Vitamin E Powder in Salt Lake City. Johnson & Johnson reports financial results Tuesday, April 14, 2020. Johnson & Johnson is ending production of its iconic talc-based Johnson's Baby Powder, which has been embroiled in thousands of lawsuits claiming it caused cancer. The world's biggest maker of health care products said Tuesday, May 19, 2020 that the discontinuation only affects the U.S. and Canada, where demand has been declining.
AP Photo/Rick Bowmer, File
FAIRLESS HILLS, Pa. (AP) — Johnson & Johnson is ending sales of its iconic talc-based Johnson's Baby Powder in the U.S. and Canada, where demand has dwindled amid thousands of lawsuits claiming it has caused cancer.
The world's biggest maker of health care products said Tuesday the talc-based powder will still be sold outside the U.S. and Canada.
"Demand for talc-based Johnson's Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising," the company said.
J&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs.
Of the cases that have been tried, J&J has had 12 wins, 15 losses and seven mistrials. All of the losses have either been overturned on appeal or are still being appealed.
The company insists, and the overwhelming majority of medical research on talc indicates, that the talc baby powder is safe and doesn't cause cancer.
"Whether or not the powder actually causes cancer, people became hesitant to use the product," Erik Gordon, a professor at University of Michigan's business school, said in an email.
J&J spokeswoman Kimberly Montagnino said the company doesn't plan to settle any of the lawsuits and "will continue to vigorously defend" the product.
The New Brunswick, New Jersey, company said the baby powder decision came as it moves to discontinue about 100 consumer health products. It said its aim is to prioritize products in high demand during the coronavirus outbreak and allow for social distancing in its manufacturing and distribution facilities.
J&J will still sell its less-popular cornstarch-based baby powder in North America.
More in Safety
Regulators Push Tesla Towards Recall
Tesla is balking at the suggestion.
Nigerian Diplomat's Family Sues Boeing over Crash
Lawyers for heirs of Abiodun Bashua accused Boeing of negligence in development of the 737 Max.
Managers Detained as 22 Trapped in Mine for 3rd Day
More than 300 workers are seeking to clear obstructions while drilling a new shaft to reach the chamber and expel dangerous fumes.
NTSB: EV Battery Fires Pose Risks to 1st Responders
New recommendations come at a time when automakers are rolling out multiple new electric vehicle models.
Crews Find Downed Jet's Data Recorder
The device is expected to help investigators determine what caused the Boeing plane to nosedive into the ocean.
Fire Extinguisher Maker Gets $12M Penalty
The allegations stem from a 2017 recall that affected nearly 40 million fire extinguishers.
Worker Killed at GM Stamping Plant
A coworker backed a forklift into a floor-to-ceiling wall unit that wasn't secured.
Antibodies from vaccine recipients successfully fended off the virus in lab dishes.
NTSB: Flight Instructor Oversight Needed
11 died in a 2019 crash piloted by a man who was not competently trained.
Environmental groups said the falling mileage and rising pollution are the outgrowth of Trump's rollbacks.
Air Pollution May Contribute to Alzheimer's and Dementia Risk
A new study links higher levels of pollution to brain shrinkage.
China's State News Urges End to Long Work Hours in Tech
The call follows the sudden death of a young employee at a leading e-commerce platform.

redpajama_set_name: RedPajamaCommonCrawl


text:
Brendan O'Brien is an American screenwriter, best known for writing 2014 film Neighbors along with Andrew J. Cohen.

Early life and education
O'Brien and his screenwriter-director friend Andrew J. Cohen were both born and grew up in Scarsdale, New York, and both went to Scarsdale Middle School, where they became friends in the sixth grade. O'Brien graduated from Georgetown University.

Career
In 2014, O'Brien co-wrote the script for the comedy film Neighbors along with Cohen, starring Zac Efron and Seth Rogen. The film was directed by Nicholas Stoller and released on May 9, 2014.

O'Brien and Cohen also co-wrote the scripts for two 2016 films, Neighbors 2: Sorority Rising and Mike and Dave Need Wedding Dates.

O'Brien and Cohen also co-wrote the 2017 comedy film The House. Cohen made his directing debut with the film.

O'Brien is set to pen the screenplay for Teenage Mutant Ninja Turtles: Mutant Mayhem, with Jeff Rowe directing. The film will release on August 4, 2023

Personal life
O'Brien is married to Amanda Headrick. They have two boys, Gabriel and Jack.

Filmography
 Neighbors (2014)
 Neighbors 2: Sorority Rising (2016)
 Mike and Dave Need Wedding Dates (2016)
 The House (2017)
 Teenage Mutant Ninja Turtles: Mutant Mayhem (2023)
 Back in Action (TBD)

References

External links

Living people
American male screenwriters
Georgetown University alumni
Film producers from New York (state)
People from Scarsdale, New York
Screenwriters from New York (state)
Year of birth missing (living people)
21st-century American screenwriters
21st-century American male writers

redpajama_set_name: RedPajamaWikipedia


text:
SSTN Blog
New York Yankees News & Opinion Blog
Yankees News
Yankees History
Around the Bases
Baseball Card Trivia
SSTN Admin
Birthday Baseball (An Occasional Series): Game 20 – July 12, 1997
By now our readers know the story… I am looking back to see how the Yankees performed on my birthday each year since I've been born and then telling the story of what took place on that summer day.
As always, whenever I do research like this, my first two stops are always Retrosheet and Baseball-Reference.
Let's head back to 1997…
On Saturday, July 12, 1997, the Yankees were at home hosting the Detroit Tigers. This was a mid-afternoon game, one that began at 4:05 p.m.
The Tigers entered the contest with a 41-46 record.
The Yankees were 50-37.
This match-up for pit Felipe Lira (5-5) for the Tigers against the Yankees' David Cone (8-4).
The Tigers sent the following line-up to face the Yankees:
Brian Hunter – cf
Bobby Higginson – lf
Travis Fryman – 3b
Tony Clark – 1b
Bob Hamelin – dh
Melvin Nieves – rf
Raul Casanova – c
Damion Easley – 2b
Deivi Cruz – ss
The Yankees countered with the following
Derek Jeter – ss
Luis Sojo – 2b
Bernie Williams – cf
Tino Martinez – 1b
Paul O'Neill – rf
Charlie Hayes – 3b
Wade Boggs – dh
Mark Whiten – lf
Joe Girardi – c
David Cone made easy work of the Tigers in the top of the first inning, retiring them in order and recording one strikeout (Brian Hunter).
In their half of the first, Bernie Williams had a two-out single, but the Yankees also failed to score.
David Cone then retired the Tigers in order again in the second inning. In that frame he struck out Bob Hamelin and Melvin Nieves.
The Yankees responded by also going down in order.
For the third, David Cone faced but three batters: a Raul Casanova ground out, a Damion Easley single (he was then caught stealing), and a Deivi Cruz strikeout.
In their half of the third, the Yankees did all sorts of things except score. Mark Whiten walked. He was thrown out trying to steal. Joe Girardi then singled. Derek Jeter flew out. Luis Sojo singled. A wild pitch put runners on second and third…but Bernie Williams bounced out to the pitcher ending the frame.
David Cone gave up a lead-off single to Brian Hunter to start the fourth, but a double play and a fly out kept the number of batters faced, again to only three. Cone was making easy work of the guys from Detroit.
The Yankees finally got things going in the bottom of the fourth. Paul O'Neill singled and then was successful in his attempt to steal second base. Charlie Hayes then singled him in putting the Yankees up 1-0. Then, they decided to waste another chance. Charlie Hayes was thrown out stealing. Wade Boggs then singled. Mark Whiten doubled. Joe Girardi then struck out. One run on four hits, just left the feeling that the Yankees were doing all in their power to not win this game.
David Cone struck out the side in the top of the fifth, but in between all those swings and misses, Bob Hamelin hit a home run to tie the game at 1-1. (Was this a strange game…or what?)
In the Yankees half of the fifth, Luis Sojo singled, Tino Martinez doubled, Paul O'Neill was intentionally walked… and the Yankees still didn't score.
David Cone then struck out Damion Easley to begin the sixth. After a Deivi Cruz ground out, Brian Hunter singled. Hunter then stole second. (It seemed that every guy who reached first decided to try to steal second.) After a Bobby Higginson walk, Travis Fryman struck out.
The Yankees went down in order. If they weren't going to score, the better method would be doing it in this manner rather than getting everyone's hopes up and not scoring anyway.
In the top of the seventh inning, the Tigers again did not score. David Cone did walk a batter (Bob Hamelin) and he recorded another strike out (Melvin Nieves).
The Yankees went back to their old tricks in the bottom of the seventh. Derek Jeter led off with a single. Luis Sojo sacrificed him to second. Bernie Williams was then intentionally walked before Mike Myers, a lefty, was brought out of the pen to face Tino Martinez and Paul O'Neill. It didn't go as planned…
Martinez walked.
O'Neill hit a sacrifice fly putting the Yankees up 2-1.
Then Charlie Hayes (now facing Dan Miceli) doubled, to plate another run, but Tino Martinez was out trying to score adding to the sense that the Yankees were just playing sloppy baseball on the bases. Still, it was now 3-1 Yankees.
In the 8th, Damion Easley walked to lead-off ending David Cone's appearance. Mike Stanton came out of the pen. Orlano Miller came up (pinch hitting for Curtis Pride who was pinch hitting for Deivi Cruz). A passed ball then allowed Easley to second before Miller became the first out on a strikeout. A Brian Hunter ground out then moved Easley to third. Bobby Higginson then walked and… attempted to steal second base. On that attempt, Damion Easley scored, even though Higginson was out. The Yankees lead though was now 3-2 and it seemed like the Tigers were just as eager as the Yankees to lose this game on the base paths.
The Yankees knew they needed some insurance runs.
Wade Boggs singled. Pat Kelly pinch ran and… stole second and went to third on a throwing error. A man on third with no outs! Mark Whiten bounced to the pitcher who threw out Pat Kelly at home. Another bad job on the bases for the Yankees. Joe Girardi then grounded out, but Whiten advanced to second. Finally, someone stepped up big. That someone was Derek Jeter who doubled home Whiten. Luis Sojo tripled home Jeter. Sojo then scored on a wild pitch that just made this whole game that much more wild. Bernie Williams then singled, but Tino Martinez grounded out.
After eight innings, the Yankees led 6-2.
A four run lead in the ninth. It should have been easy. Travis Fryman walked. He moved to second on a ground out. Future Yankees coach, Phil Nevin, then pinch hit for Bob Hamelin and walked.
This convinced the Yankees to bring in Mariano Rivera.
The great closer made easy work of it all. He struck out Melvin Nieves and Raul Casanova to end the game and earn the save.
The Yankees won again!
In the next installment, we'll head to Tampa Bay for the 1998 Yankees to face the Devil Rays and some late game explosions…
Yankees Record on July 12 (in this series – since 1968): 17-3.
(There were no games played on July 12 in 1971, 1976, 1978, 1981, 1982, 1988, 1989, 1993, 1994, and 1996.)
Derek Jeter on July 12 (to date): 2 for 5 (.400), 2 runs, 1 RBI, 1 SO
Mariano Rivera on July 12 (to date): .2 innings, no runs, no hits, no walks, 2 strikeouts, 1 save (0.00)
Don Mattingly on July 12 (in his career on July 12): 12 for 31 (.387), 2 2B, 2 HR, 8 RBI, 2 BB, SO
Graig Nettles (as a Yankee on July 12): 33 AB, 7 hits (.212), 1 run, 5 strikeouts, 4 walks. 1 RBI (I had hoped that my favorite player would have done better on my birthday.)
#BirthdayBaseball
Yankees Roster Now...
Looking At The Top 100 Prospects List
Dr. Sem's Saturday Yankees Show (1/28/23)
Start Spreading the News is the place for some of the very best analysis and insight focusing primarily on the New York Yankees.
(Please note that we are not affiliated with the Yankees and that the news, perspectives, and ideas are entirely our own.)
Have a question for the Weekly Mailbag?
Click below or e-mail:
SSTNReaderMail@gmail.com
Mailbag Gmail
SSTN is proudly affiliated with Wilson Sporting Goods! Check out our press release here, and support us by using the affiliate links below:
Start Spreading the News is affiliated with Wilson Sporting Goods and is powered by SendToNews


Apologies for the lack of updates, I was away in Jakarta for a few days, then I had food poisoning…quite badly…so spent a couple of days either in bed or on the toilet.
Anyway, a while back I went to The Eye on Malaysia, another waste money project sponsored by the G.
I went twice, the first time I conveniently forgot my tripod, so no decent shots..but thankfully there wasn't fireworks that night so I didn't miss anything.
I duly went back the next weekend, and camped out an hour or so before the show, and got what I wanted!
It was my first time taking fireworks, quite an experience.
This 30 second exposure spent quite a long time as my wallpaper!
Do view Large on Black for details!
It really was a fantastic fireworks show, I was quite surprised. It was totally worth the wait!
I did actually ride on the eye, not that it was really worth it, you can't see anything that you haven't already seen if you've been up the KL tower or on Petronas bridge.
The crowds at the eye were pretty massive every day.
As usual let me know what you think of the pics and which is your fave! Cheers.
19 Responses to The Eye on Malaysia – Taman Tasik Titiwangsa – Fireworks!
Without a doubt, the third picture is the most awesome!
yea the third picture is good, the second one looks nice too. i kinda like how the lights from the ferris wheel and KLCC and that building(dewan bahasa & pustaka? correct me if im wrong lol) blend with the black sky and the waters.
im curious though about why all the ferris wheel in the pictures look like its spinning really freaking fast, or is that because of some photography technique? im not sure :X never really got into photography.
I'm no photography expert myself, but if I'm not mistaken, you can get the effect ST has here by using a slower shutter speed.
lovely pics as usual. ky is mean!!
Superb! Nice pictures and full of colors that cover the night.
wow, good shots, i like the third pic too.
Nice work. The best pix of the Eye of Malaysia I've seen.
Wonderful pictures, the best I've ever seen, and the fireworks, they are like orgasms… LOL, beautiful!
Azmeen: Thanks 🙂 It still rocking as my wallpaper.
moonss: Thanks dude. Yah the lights and the wheel look like that because of slow shutter speed, most were between 10-30 seconds of exposure. And yah it's Istana Budaya.
suanie: Ahaha yeah a bit scary.
pik: Nice shots! Sadly the fireworks were only on in January…no more. You can still get some nice shots though, I recommend going around sunset.
Louis Pang: I love your wedding stuff, glad you like the pictures.
zidni: I use a Nikon D200.
Very nice pictures, I like the 3rd one the most. I wish I have a chance to capture all these, hehe. Wish I could be there to pay a visit next year.
GhostTedd: I don't think the eye will still be there next year, good luck tho!


text:
package org.jetbrains.jps.model.java;

import org.jetbrains.annotations.NotNull;
import org.jetbrains.annotations.Nullable;
import org.jetbrains.jps.model.JpsElement;

/**
 * @author nik
 */
public interface JpsJavaSdkTypeWrapper {
  @Nullable
  String getJavaSdkName(@NotNull JpsElement properties);
}

redpajama_set_name: RedPajamaGithub


As I'm writing the title of this post, I acknowledge how different SEO-centric writing is from writing as a contemplative practice. I can't deny the appeal of being discovered through Google and yet strategizing my whole output around a targeted keyword feels limiting and opportunistic. The second I try to cram "pink flamingo" 5 times in a post inconspicuously, I'm not having fun anymore. Pink flamingo.
Allow me to indulge my romantic side for a second: my favorite part of the writing process is starting a piece and not knowing where it'll take me. I started this new journal as an antithesis to the influencer content I was producing that steadily became more and more vacuous as the industry shifted. This is my happy place to explore, distill and record spontaneous thoughts.
Being an influencer stopped feeding me artistically or mentally because the type of content that was considered successful was superficial to the point of preventing me from building genuine relationships with my followers.
Only a decade ago, the prototype for influencer marketing was fashion blogging.
When fashion blogging started becoming a legitimate career, it felt like a revelation to get an insider glimpse at fashion week through the eyes of a someone relatable. Bloggers came on the scene with a fresh perspective and no advertising ties. The initial hype around style bloggers created a sense of authenticity in an industry where mainstream approval is often mistaken for quality and profundity.
The proliferation of fashion blogging as a career choice eventually gave way to being an influencer. It's a slightly vague term, meaning you make a living though affecting other people's (consumer) decisions. By occupation, influencers are mostly models, bloggers, musicians, and a whole category of people whose real job you can't quite pinpoint by looking at their feed.
The premise of the influencer lifestyle is that you have a loyal audience that trusts your expertise enough to follow your life advice (often vague aspirational mantras) and buy into whatever you are making a commission off. When we see someone with many followers advertising a service, we feel validated by the numbers next to their name.
It becomes exploitative once the influencer takes advantage of their followers and flashes their own experience as universal advice. Just like you don't know anyone else's story, you can't give valuable advice about their metabolism, personal growth or style without having another frame of reference besides your own. It's important to remember that just because you're doing something on social media and there are a few eyeballs on you, that doesn't make you an expert.
This frustration and the pressure and boredom of always creating a single type of posts, aspirational to my followers (beautiful location, cute outfit, living grand), left me feeling jaded and disappointed with an industry that I joined because I wanted to do something creative, connected and novel with my spare time.
When I decided to quit being an influencer, I rediscovered a passion for writing that didn't aim to impress or promote. Hopefully, here we can have a more honest conversation. Not aiming to be more substantial or important, but juicier, more thoughtful and interactive. It's lovely to have you along for the ride. Feel free to say hi below!
Next Post (n)	Allie X Serves Dreamy Post-Apocalyptic Pop in "Focus"


An exclusive collectors print featuring Paul Kidby's iconic 2018 portrait of Terry Pratchett, as seen on the book jacket of Terry Pratchett HisWorld, the Official Exhibition Companion.
Each print is hand signed and numbered and the edition is limited to 2000 copies worldwide. Printed on 350gm silk paper. Dimensions 490 x 350mm. Prints are despatched rolled in acid free tissue in a postal tube.
Price includes Postage & Packing for UK deliveries.


text:
Date of dinosaur extinction fixed more accurately than ever before
The demise of the dinosaurs is the world's ultimate whodunit. Was it a comet or asteroid impact? Volcanic eruptions? Climate change?
In an attempt to resolve the issue, an international team of scientists have determined the most precise dates yet for the dinosaur extinction 66 million years ago and for the well-known impact that occurred around the same time. The new extinction date is precise to within 11,000 years.
In a paper published today in the journal Science, researchers from the Berkeley Geochronology Center (BGC), the University of California, Berkeley, the Scottish Universities Environmental Research Centre (University of Glasgow) and Vrije University, conclude that the dates of the events are so close that it's likely the impact of the comet or asteroid, if not wholly responsible for the global extinction, at least dealt the death blow to the dinosaurs.
"The impact was clearly the final straw that provided the tipping point," said Paul Renne, BGC director and professor in residence of earth and planetary science at the University of California, Berkeley. "We have shown that these events are synchronous to within a gnat's eyebrow and therefore the impact clearly played a major role in extinctions, but it probably wasn't just the impact."
The revised dates clear up lingering confusion over whether the impact actually occurred before or after the extinction, which was characterized by the almost overnight disappearance from the fossil record of land-based dinosaurs and many ocean creatures. The new date for the impact – 66,038,000 years ago – is the same within error limits as the date of the extinction, said Renne, making the events simultaneous.
At the Scottish Universities Environmental Research Centre in East Kilbride, a team led by Dr Darren Mark conducted independent argon-argon analyses which confirmed the results from the US. Argon-argon dating uses a mass spectrometer to measure the ratio of radioactive potassium in a sample of rock to its decay product, argon. The amount of argon in a sample allows researchers to use rocks as incredibly slow clocks.
Dr Mark said: "This study shows the power of high precision geochronology. Many people think precision is just about adding another decimal place to a number, but it's far more exciting than that. It's more like getting a sharper lens on a camera. It allows us to dissect the geological record at greater resolution and piece together the sequence of Earth history.
"We're proud to have contributed to this important study. It's another success for SUERC which has recently re-dated the super-eruption deposits of Yellowstone showing the super-eruption deposit was a product of multiple eruptions."
The extinction of the dinosaurs was first linked to a comet or asteroid impact in 1980 by the late UC Berkeley professors Luis and Walter Alvarez. A 110-mile-wide crater in the Caribbean off the Yucatan coast of Mexico is presumed to be the result of that impact. Called Chicxulub, the crater is thought to have been excavated by an object six miles across that threw into the atmosphere debris still found around the globe as glassy spheres or tektites, shocked quartz and a layer of iridium-enriched dust.
The international team decided last year to re-date the dinosaur extinction, which occurred at the boundary between the Cretaceous and Tertiary periods – the KT boundary – after recalibrating the 20-year-old accepted date and discovering that it now occurred 180,000 years BEFORE the impact. That earlier date was obtained in 1993 by BGC researchers using the argon-argon method.
Renne and his BGC colleagues dated tektites from Haiti to determine how long ago the impact occurred. The tektite results agreed with recalibrated previous data but were more precise. They did the same for altered volcanic ash collected from the Hell Creek Formation in Montana, the source of many dinosaur fossils and one of the best sites to study the change in fossils from before and after the extinction.
Despite the synchronous impact and extinction, Renne cautions that this doesn't mean that the impact was the sole cause. Dramatic climate variation over the previous million years, including long cold snaps amidst a general Cretaceous hothouse environment, probably brought many creatures to the brink of extinction and the impact kicked them over the edge.
One cause of the climate variability could have been a sustained series of volcanic eruptions in India that produced the extensive Deccan Traps. Renne and Mark plan to re-date those volcanic rocks to get a more precise measure of their duration and onset relative to the dinosaur extinction.
Renne and his colleagues also dated rocks above the KT boundary where previous researchers had looked at carbon isotopes, and concluded that Earth's atmospheric carbon cycle returned to normal within about 5,000 years of the impact. This is in stark contrast to the world's oceans, which studies show took between 1 and 2 million years to return to normal. Renne attributes this to a sluggish recovery of pre-impact ocean circulation patterns, though he concedes that this remains poorly understood.
The study's results also clarify some inconsistencies between different estimates for the age of the KT boundary based on Earth's orbital rhythms recorded in sedimentary rocks. The new independent results agree within the margins of error with an age of 65,957,000 years determined using this approach by Dutch colleagues Frederik J Hilgen of Utrecht University and Klaudia F. Kuiper of Vrije University.
Renne's colleagues, in addition to Mark, Hilgen and Kuiper, are UC Berkeley graduate student William S. Mitchell III; BGC scientists Alan L. Deino and Roland Mundil; Leah E. Morgan of the Scottish Universities Environmental Research Center; and Jan Smit of Vrije University in Amsterdam.
The work was supported by the Ann and Gordon Getty Foundation, UC Berkeley's Esper S. Larsen Jr. Fund and National Science Foundation.
The Scottish Universities Research Centre's Argon Isotope Facility is funded by the Natural Environment Research Council (NERC).
For more information contact Ross Barker in the University of Glasgow Media Relations Office on 0141 330 8593 or email ross.barker@glasgow.ac.uk or Robert Sanders, UC Berkeley media relations, on (510) 643 6998 / rsanders@berkeley.edu
First published: 7 February 2013
<< February
<< previous story
next story >>


text:
CLXT
Calyxt Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 3, 2022 - 4:01 pm
—Successfully produced squalene, an important ingredient for personal care products and vaccine adjuvants—
—Continued to progress customer acquisition activities, including evaluating an incremental 37 customer chemistries for development using PlantSpring™ and BioFactory™ technologies—
—Signed agreement with Evologic Technologies to further develop and scale production of its Plant Cell Matrix™ technology platform—
—Continuing board-level evaluation of a full range of potential strategic alternatives to maximize shareholder value—
—Selected for membership to BioMADE, a Department of Defense-sponsored initiative that brings together industrial, academic and non-profit entities to advance US bioindustrial manufacturing—
—Management to host conference call and webcast today at 4:30 p.m. ET—
ROSEVILLE, Minn., Nov. 3, 2022 -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced operating and financial results for its third quarter ended September 30, 2022.
"Last month, we announced we had made substantial technical progress by successfully using a Calyxt-engineered Plant Cell Matrix to produce squalene. This is a desired ingredient for many cosmetics products and also serves as critical vaccine adjuvant. This milestone is another validation of the promise of our platform to engineer plant metabolism to produce innovative high value chemistries for use in our customers' materials and products across the end markets of cosmeceuticals, nutraceuticals, and pharmaceuticals," said Michael A. Carr, President and Chief Executive Officer at Calyxt. "Further, in the third quarter, we continued to progress our customer acquisition activities and evaluated 37 additional customer demand driven chemistries for development and production. These achievements, which come despite unprecedented headwinds in the capital markets and macro economy and resulting liquidity challenges for the Company, reflect our determination to drive our business forward and realize value for our shareholders, while continuing to carefully manage operating expenses."
Mr. Carr added: "In addition, we signed an agreement with Evologic Technologies, our first global infrastructure partner, which enables us to power our speed-to-scale strategy and supports our ability to meet the growing interest in high-quality sustainable ingredients across the cosmeceutical, nutraceutical, and pharmaceutical markets. With our new pilot program initiated, our first infrastructure partner on board, and additional discussions ongoing, we are encouraged by the increasing traction of our business. We also were selected for membership in BioMADE, a Department of Defense-sponsored manufacturing innovation initiative, which will give us access to a network of industrial and academic entities focused on advancing bioindustrial manufacturing and will enable us to apply for government grants to progress research in plant-based biomanufacturing. In all, these accomplishments made for a highly productive quarter notwithstanding current capital constraints."
Key accomplishments in the third quarter of 2022, and through the date of this press release, include the following:
Chemistries under Development for Potential Customers
On October 25, 2022, Calyxt announced that using a Calyxt-engineered Plant Cell MatrixTM biomass, it has successfully produced squalene, an important ingredient in many personal care products and vaccine adjuvants, including several strands of flu and COVID-19 vaccines. Traditionally sourced from shark liver, many companies who require the ingredient for their products have already begun to seek out alternative squalene sources that represent a more sustainable path forward. With the increasing demand for natural ingredients in cosmetics along with the urgency to develop more vaccines that are effective at boosting our immune response, the global squalene market represents a significant and growing market opportunity.
In the third quarter, Calyxt received 37 new chemistries from potential customers for evaluation, bringing the total number of chemistries cumulatively evaluated for development with PlantSpring for production in its BioFactory to 132. Of the 132 chemistries, 43 have met Calyxt's target product profile, or TPP, criteria and, subject to prioritization in light of available resources, are subject to further evaluation and discussion with the potential customers. Additionally, the evaluated chemistries include several that were identified by potential customers as having been unsuccessfully attempted by others in the synthetic biology industry.
Current Customer Projects Under Development are on Track
Calyxt continued to progress the pilot project for a major consumer packaged goods company with delivery of the plant-based chemistry expected in early 2023. This delivery has the potential to lead to a development agreement for this and potentially other chemistries.
Calyxt continued to progress the development of its soybean-based palm oil alternative plant trait, and it expects to achieve the first $100 thousand milestone payment as early as the fourth quarter of 2022, with the overall project scheduled for completion in the first quarter of 2024, at which time the second milestone payment of $100 thousand would be due.
Signed Agreement with First Global Infrastructure Partner to Enable Growth and Scale of Calyxt's Proprietary Technology
On October 6, 2022, Calyxt announced that it signed an agreement with its first manufacturing partner, Evologic Technologies GmbH (Evologic), to further develop and scale Calyxt's proprietary Plant Cell Matrix (PCM™) technology platform. The agreement supports the continued build-out of Calyxt's plant-based synthetic biology capabilities. Evologic's contract development and manufacturing services, based on its proprietary bioprocess platform and technology, support companies delivering unique and sustainable bioproducts. Under the terms of the agreement, Evologic will work alongside Calyxt to grow and scale Calyxt's proprietary PCM technology. Specifically, Evologic will advance the manufacturing of PCM-derived compounds and establish proof of concept for the subsequent scaling of multiple PCMs simultaneously for commercial production. Calyxt anticipates sending a PCM that will produce squalene to Evologic for scaling in the fourth quarter of 2022.
Evaluation of Strategic and Financing Alternatives
On September 22, 2022, Calyxt announced that its Board of Directors is evaluating a full range of potential strategic alternatives and that it had engaged Canaccord Genuity as an advisor. The evaluation of these alternatives as well as the engagement of Canaccord Genuity demonstrates Calyxt's management and Board of Directors' commitment to maximize shareholder value.
While Calyxt continues to actively assess market conditions and to pursue potential financing alternatives to fund its operations, in light of Calyxt's current liquidity challenges and market headwinds, management has implemented cost reduction and other cash-focused measures to manage liquidity and prioritize capital resources.
Gained Membership Inclusion to BioMADE
On November 1, Calyxt announced that it had been selected for membership in BioMADE, a Department of Defense-sponsored manufacturing innovation initiative. As a result, Calyxt joins a network of industry, academic, not-for-profit and United States government members dedicated to innovating and growing the bioeconomy. Membership also enables Calyxt to apply for government grants to advance research in plant-based biomanufacturing.
Additional Updates
In early November 2022, Calyxt reached a settlement with one of its technology vendors regarding alleged intellectual property infringement. As a result of the settlement, Calyxt will receive $750 thousand upon execution of an amended master services agreement (MSA) and another $750 thousand by January 31, 2023. The execution of the MSA is anticipated to occur in the fourth quarter of 2022.
Financial Results for the Three Months Ended September 30, 2022
Cash, cash equivalents, and restricted cash totaled $7.2 million as of September 30, 2022.
Revenue was nominal in the third quarter of 2022 compared to $7.8 million in the third quarter of 2021. The decrease in revenue was driven by the late 2021 completion of the wind-down of the Company's soybean product line. Revenue in the third quarter of 2022 was primarily associated with the Company's agreement with a food ingredient manufacturer to develop a palm oil alternative.
Total operating expenses were $6.2 million in the third quarter of 2022 compared to $6.4 million in the third quarter of 2021. The decrease was primarily driven by improved gross margins as a result of lower operating expenses in the period, partially offset by the Company's adoption of the lease accounting standard which shifted amounts previously reported in interest, net to operating expenses.
Net loss was $6.0 million in the third quarter of 2022 compared to $7.3 million in the third quarter of 2021. The improvement in net loss was driven by the late 2021 completion of the wind-down of the Company's soybean product line, lower operating expenses, a decrease in interest, net resulting from the adoption of the lease accounting standard which shifted amounts previously reported in interest, net to operating expenses, and non-operating income (expenses) including the mark-to-market of the Common Warrants derivative liability, which declined in value due to a decline in stock price in 2022. Net loss per share was $0.13 in the third quarter of 2022 compared to $0.20 in the third quarter of 2021. The improvement in net loss per share was driven by the improvement in net loss and a year-over-year increase in weighted average shares outstanding.
Adjusted net loss was $6.2 million in the third quarter of 2022 compared to $9.1 million in the third quarter of 2021. The improvement in adjusted net loss was driven by the completion of the wind-down of the soybean product line in late 2021. Adjusted net loss per share was $0.13 in the third quarter of 2022 compared to $0.24 in the third quarter of 2021. The improvement in adjusted net loss per share was driven by the improvement in adjusted net loss and a year-over-year increase in weighted average shares outstanding.
On October 3, 2022, Calyxt entered into an amendment to its Open Market Sale Agreement with Jefferies that enables it, subject to a maximum sale of up to one-third of Calyxt's public float in any twelve month period, to offer and sell up to 15,661,000 shares of its common stock. From that date to the date of this release, Calyxt issued 2.0 million shares of its common stock, raising $0.1 million, net of offering fees and expenses. As a result of the issuance of these shares, Cellectis, S. A., once Calyxt's majority shareholder, now has an ownership percentage of 49.1 percent.
"We continue to be focused on the effective and prudent use of our cash resources and we have reduced costs while executing on near term milestones. In the third quarter of 2022 we achieved the lowest burn rate the Company has seen in recent years," said Bill Koschak, Chief Financial Officer at Calyxt. "Our cash burn in the third quarter of 2022 was $4.7 million, $1.2 million less than the second quarter of 2022. The results of our cost saving efforts, which are ongoing and include discretionary actions in management's control, and the legal settlement, have provided cash runway into the second quarter of 2023. Calyxt is also exploring its ability to pursue certain U.S. government grant programs that were previously unavailable to us because of Cellectis' majority ownership."
Third Quarter 2022 Results Conference Call
Calyxt's President and Chief Executive Officer, Michael A. Carr, and Chief Financial Officer, Bill Koschak, will host a conference call discussing Calyxt's results for the third quarter of 2022 and provide a business update. The conference call will be webcast and accessible via the investor relations section of Calyxt's website at www.calyxt.com.
To access the call, please use the following information:
4:30 p.m. ET, 1:30 p.m. PT
Toll Free dial-in number:
Toll/International dial-in number:
Conference ID:
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. The conference call will also be broadcast live and available for replay via the investor relations section of the company's website at www.calyxt.com.
A replay of the conference call and webcast will be available for 30 days following the event.
About the PlantSpring™ Technology Platform and BioFactory™ Production System
Calyxt's technology platform, PlantSpring, is founded on the Company's more than a decade of experience engineering plant metabolism, and incorporates its scientific knowledge, its proprietary systems, tools, and technologies; and an expanding set of related capabilities. In PlantSpring, the Company identifies metabolic pathways to produce plant-based chemistries, designs strategies to reprogram host cells, engineers plant cell metabolism to optimally produce targeted compounds, and produces those targeted compounds at laboratory scale. The Company has implemented AIML capabilities for the identification of targets for editing specific genetic pathways and continues to develop AIML capabilities across the PlantSpring platform, which will enable learning and adaptation of knowledge gained from past activity and are expected to be combined with predictive analytics to rapidly prototype and provide feedback, accelerate the time to complete the development cycle and help mitigate the risk associated with commercial scale-up. As a result, Calyxt believes it can develop biomolecules in plants for customers at both a greater breadth and level of complexity and at faster speeds than its competitors in the synthetic biology industry. The output from the PlantSpring platform integrates with the Company's BioFactory production system. The Company uses the term "compounds" to describe compounds, molecules, and plant-based chemistries interchangeably.
The BioFactory is a bioreactor-based production system that is designed to be capable of continuous production of plant-based chemistries. The bioreactor can be of any size depending upon factors including yield and titer necessary to reach the required commercial scale. For production, multicellular Plant Cell Matrix™ (PCM™) structures are placed inside the bioreactor, and growth media bathes the PCM structures to provide them with nutrition, which differentiates the Company's process from other methods that require complete submersion of cells in growth media and/or the application of hormones to facilitate growth. A PCM structure is a living system of various cell types, which is designed to emulate the intercellular metabolism of an entire plant, which grows over time, produces, and stores, or excretes, the target chemistries. The growth media is the feedstock of the BioFactory production system and contains the essential inputs to support growth of the PCM structures and necessary chemistry production. The growth media is expected to be reused throughout the production cycle, which may run for an extended time period. To scale production in the BioFactory productions system, the Company expects to move the PCM structures from its current bioreactor into larger capacity bioreactors or groups of bioreactors. Calyxt began running lab-scale bioreactors in early 2021. The Company's first pilot-scale bioreactor became operational in December 2021 and is scalable up to 200 liters. The pilot stage of development takes a compound developed with the PlantSpring platform through to commercial production. Depending on the compound to be produced, there may be a range of vessel sizes between the initial pilot facility and the commercial production facility. The Company's current plan is to engage third parties, referred to as infrastructure partners, for at-scale commercial production. Infrastructure partners are likely to be companies with processing assets that can be converted from current production to the Company's bioreactor-based approach. If an infrastructure partner is used for production, the Company expects to pay a fee for that production. Because of the expected modular nature of the BioFactory production system and the types of high value compounds the Company expects to develop for customers, it is also possible that commercial production could also occur in a customer's in-house facility. The Company expects to expand the scope of its pilot facilities based on customer demand, and the scope of production could extend, subject to regulatory and other considerations, outside the United States. Because of its production methodology, Calyxt believes the BioFactory has the potential to be one of the most sustainable production systems across industries.
About Calyxt
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.
Calyxt Media Contact:
Calyxt Investor Relations Contact:
Brennan Burks
Calyxt, Inc.
brennan.burks@calyxt.com
Kimberly Minarovich/ Cameron Willis
Argot Partners
investors@calyxt.com
Calyxt Business Development Contact:
Gerry Nuovo
Senior Vice President of Business Development
contact@calyxt.com
USE OF NON-GAAP FINANCIAL INFORMATION
To supplement the Company's financial results prepared in accordance with GAAP, it has prepared certain non-GAAP measures that include or exclude special items. These non-GAAP measures are not meant to be considered in isolation or as a substitute for financial information presented in accordance with GAAP and should be viewed as supplemental and in addition to the Company's financial information presented in accordance with GAAP. Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures. In addition, other companies may report similarly titled measures, but calculate them differently, which reduces their usefulness as a comparative measure. Management utilizes these non-GAAP metrics as performance measures in evaluating and making operational decisions regarding the Company's business.
The Company's 2021 non-GAAP financial measures reflect adjustments for certain commodity derivatives entered into in connection with its soybean product line. As a result of the completed wind-down of this product line in late 2021, the Company held no commodity derivative contracts as of September 30, 2022.
The Company presents adjusted net loss, a non-GAAP measure, and defines it as net loss adjusted for (i) unrealized gains and losses associated with commodity derivatives entered into to hedge the change in value of fixed price grain inventories and fixed price grain production agreements that should be recognized in the future when the underlying inventory is sold, (ii) gains and losses from commodity derivatives realized in prior periods but associated with inventory sold in the current period, (iii) net realizable value adjustments to inventories occurring in the period which otherwise would have been recognized in the future when the underlying inventory is sold, and (iv) net realizable value adjustments recognized in prior periods but associated with inventory sold in the current period, and excluding cash-based Section 16 officer transition expenses, the recapture of non-cash stock compensation associated with the departure of Section 16 officers, the gain upon the extinguishment of the Payroll Protection Program (PPP) loan, and non-operating income (expenses). The foregoing adjustments are those necessary to present the underlying gross profit of the Company's soybean product line for the 2021 periods presented, together with the corresponding adjustments to the extent applicable to the corresponding 2022 periods presented.
The Company provides in the table below a reconciliation of net loss, which is the most directly comparable GAAP financial measure, to adjusted net loss. The Company provides adjusted net loss because it believes that this non-GAAP financial metric provides investors with useful supplemental information in light of the Company's business model during the periods presented, as the amounts being adjusted affect the period-to-period comparability of net losses and financial performance.
The table below presents a reconciliation of net loss to adjusted net loss:
In Thousands
Net loss (GAAP measure)
$ (5,950 )
$ (14,054 )
Non-GAAP adjustments:
Commodity derivative impact, net
(2,073 )
Net realizable value adjustment to inventories
(88 )
Section 16 officer transition expenses
Recapture of non-cash stock compensation
Gain upon extinguishment of Payroll Protection Program loan
Non-operating income (expenses)
Adjusted net loss
The Company presents adjusted net loss per share, a non-GAAP measure, and defines it as net loss per share adjusted for (i) unrealized gains and losses associated with commodity derivatives entered into to hedge the change in value of fixed price grain inventories and fixed price grain production agreements that should be recognized in the future when the underlying inventory is sold, (ii) gains and losses from commodity derivatives realized in prior periods but associated with inventory sold in the current period, (iii) net realizable value adjustments to inventories occurring in the period which otherwise would have been recognized in the future when the underlying inventory is sold, and (iv) net realizable value adjustments recognized in prior periods but associated with inventory sold in the current period, and excluding cash-based Section 16 officer transition expenses, the recapture of non-cash stock compensation associated with the departure of Section 16 officers, the gain upon the extinguishment of the PPP loan, and non-operating income (expenses). The foregoing adjustments are those necessary to present the underlying gross profit of the Company's soybean product line for the 2021 periods presented, together with the corresponding adjustments to the extent applicable to the corresponding 2022 periods presented.
The Company provides in the table below a reconciliation of net loss per share, which is the most directly comparable GAAP financial measure, to adjusted net loss per share. The Company provides adjusted net loss per share because it believes that this non-GAAP financial metric provides investors with useful supplemental information in light of the Company's business model during the periods presented, as the amounts being adjusted affect the period-to-period comparability of net losses per share and financial performance.
The table below presents a reconciliation of net loss per share to adjusted net loss per share:
Net loss per share (GAAP measure)
$ (0.13 )
(0.06 )
Adjusted net loss per share
This communication contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, you can identify these statements by forward-looking words such as "anticipates," "believes," "continue," "estimates," "expects," "intends," "may," "might," "plans," "predicts," "projects," "should," "targets," "will," or the negative of these terms and other similar terminology. Forward-looking statements in this report include statements about the Company's future financial performance, including its liquidity and capital resources, cash runway and its ability to continue as a going concern; its product pipeline and development; its business model and strategies for the development, commercialization and sales of commercial products; commercial demand for its synthetic biology solutions; the development and deployment of its PlantSpring technology platform; the ability to scale production capability for its BioFactory production system; potential development agreements, partnerships, customer relationships, and licensing arrangements and their contribution to its financial results, cash usage, and growth strategies; and anticipated trends in its business. These and other forward-looking statements are predictions and projections about future events and trends based on the Company's current expectations, objectives, and intentions and are premised on current assumptions. The Company's actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors, including, but not limited to: any adverse impact of the Company's cost reduction measures and its pursuit and evaluation of a broad range of strategic alternatives on its relationship with employees and third-parties, including ongoing negotiations with potential customers; whether or not the Company is able to identify and consummate an acceptable strategic alternative pursuant to its ongoing exploration of such transactions; the impact of increased competition, including competition from a broader array of synthetic biology companies; competition for customers, partners, and licensees and the successful execution of development and licensing agreements; disruptions at its key facilities, including disruptions impacting its BioFactory production system; flaws in AIML algorithms, insufficiency of data inputs required by such algorithms, and human error in interacting with AIML; changes in customer preferences and market acceptance of its products; changes in market consensus as to what attributes are required for a product to be considered "sustainable"; the impact of adverse events during development, including unsuccessful pilot production of plant-based chemistries or field trials; the impact of improper handling of its product candidates during development; failures by third-party contractors; inaccurate demand forecasting or milestone and royalty payment projections; the effectiveness of commercialization efforts by commercial partners or licensees; disruptions to supply chains, including raw material inputs for its BioFactory; the impact of changes or increases in oversight and regulation; disputes or challenges regarding intellectual property; proliferation and continuous evolution of new technologies; management changes; changes in macroeconomic and market conditions, including inflation, supply chain constraints, and rising interest rates; dislocations in the capital markets and challenges in accessing liquidity and the impact of such liquidity challenges on the Company's ability to execute on its business plan; the severity and duration of the evolving COVID-19 pandemic and the resulting impact on macro-economic conditions; and other important factors discussed in Part I, Item 1A, "Risk Factors" in the Company's filings with the SEC, included in Part I, Item 1A of its Annual Report on Form 10-K for the year ended December 31, 2021, which was filed with the SEC on March 3, 2022 (its Annual Report) and its subsequent reports on Forms 10-Q and 8-K filed with the SEC. Any forward-looking statements made by management of the Company are based only on currently available information and speak only as of the date of this report. Except as otherwise required by securities and other applicable laws, the Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change.
(In Thousands, Except Par Value and Share Amounts)
Non-current restricted cash
Land, buildings, and equipment
Operating lease right-of-use assets
Other non-current assets
Accrued compensation
Due to related parties
Current portion of financing lease obligations
Financing lease obligations
Operating lease obligations
Other non-current liabilities
Common stock, $0.0001 par value; 275,000,000 shares authorized; 46,909,420 shares issued and 46,809,268 shares outstanding as of September 30, 2022, and 38,874,146 shares issued and 38,773,994 shares outstanding as of December 31, 2021
Common stock in treasury, at cost; 100,152 shares as of September 30, 2022, and December 31, 2021
(209,314 )
See accompanying notes to these consolidated financial statements.
(In Thousands Except Shares and Per Share Amounts)
Selling, general, and administrative
(19,057 )
Interest, net
Basic and diluted net loss per share
Weighted average shares outstanding – basic and diluted
Anti-dilutive stock options, restricted stock units, performance stock units, and common stock warrants
Adjustments to reconcile net loss to net cash used by operating activities:
Unrealized (gain) loss on mark-to-market of common stock warrants
Due to/from related parties
Net cash used by operating activities
Proceeds from sales of short-term investments
Purchases of land, buildings, and equipment
Net cash (used by) provided by investing activities
Proceeds from the issuance of common stock, and pre-funded warrants
Costs incurred related to the issuance of common stock, pre-funded warrants, and common warrants
Repayments of financing lease obligations
Proceeds from the exercise of stock options
Net cash provided by (used by) financing activities
Net (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash – beginning of period
Cash, cash equivalents, and restricted cash – end of period
View original content to download multimedia:https://www.prnewswire.com/news-releases/calyxt-reports-third-quarter-2022-financial-results-and-provides-corporate-update-301668044.html
SOURCE Calyxt, Inc.
Nasdaq:CLXT
Calyxt Inc
Latest CLXT News
11/18/22 11:00 AM Calyxt Achieves Phase 1 Milestone in Collaboration Agreement to Develop Alternative to Palm Oil
11/17/22 4:01 PM Calyxt Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
11/01/22 7:00 AM Calyxt Joins Bioindustrial Manufacturing and Design Ecosystem (BioMADE), a Department of Defense Initiative, to Advance Sustainable Plant-Based Biomanufacturing
10/27/22 7:00 AM Calyxt to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Thursday, November 3, 2022, at 4:30 p.m. Eastern Time
10/25/22 7:00 AM Calyxt Successfully Produces Plant-Based Squalene, an Important Ingredient in Personal Care Products and Critical Vaccine Adjuvants
CLXT Data
Industry All Other Grain Farming
Website www.calyxt.com
Security name Calyxt Inc
Sector Agriculture, Forestry, Fishing and Hunting
Sic code 119
All Other Grain Farming
About Calyxt Inc
Calyxt, based in Roseville, Minnesota, is a technology company with a mission to deliver plant-based innovations for a better world. Founded in 2010, Calyxt uses its proprietary TALEN® gene editing technology to work with world-class partners via technology licensing, product development, and seed sale arrangements to revolutionize the way the world uses plants to solve problems.


text:
Amelia Yeomans, née Amelia LeSuer à Québec le  et morte le  à Calgary, est une suffragette, médecin et une activiste pour la tempérance québécoise.

Elle est active à Winnipeg vers la fin du .

Biographie

Jeunesse
Amelia Yeomans est née à Québec le . Elle est la fille de Peter LeSueur et Barbara Dawson. Elle se fait scolariser à la maison par ses parents qui accordent une grande importance à l'éducation. En 1860, elle épouse le  Augustus A. Yeomans qui plus tard est employé comme aide-chirurgien dans l'armée américaine. En 1862, les Yeomans déménagent aux États-Unis durant la guerre de Sécession. Amelia Yeomans eut deux enfants, Lilian et Charlotte, avant la mort inopinée de son époux en 1878.

Formation
En 1879, Amelia Yeomans décide de poursuivre des études de médecine à l'université d'état du Michigan. Elle y rejoint sa fille Lilian Yeomens qui a commencé ses études un an avant elle. Les deux femmes y subissent les préjudices courants à l'époque envers les femmes qui étudient dans un domaine traditionnellement réservé aux hommes.

Carrière en médecine sociale
Après l'obtention de son diplôme de médecin, Amelia Yeomans rejoint sa fille Lilian à Winnipeg en 1883 où elles pratiqueront toutes les deux la médecine. Cependant, elle ne recevra pas une licence officielle avant 1885. Amelia et Lilian Yeomens décident de se spécialiser en obstétrique et s'intéressent généralement aux maladies affectant femmes et enfants. En tant que praticiennes de médecine sociale, les Yeomens s'intéressent non seulement au traitement physique, mais aussi à la cause sociale des maladies. Elle dénonce les conditions de prisonnières, de travailleuses du sexe et de femmes sans emploi, et rend les hommes responsables. Durant sa carrière, Amelia Yeomans organise une conférence réservée aux hommes dans le but de les éduquer en ce qui concerne les maladies vénériennes et solliciter leur appui pour l'amélioration de la condition féminine.

Activisme
Son expérience dans le travail fait réaliser à Amelia Yeomans le rôle important et destructeur que joue l'alcool dans la société. Elle se joint alors à la 'Woman's Christian Temperance Union (WCTU) et milite pour la prohibition de l'alcool. Elle réalise aussi que la réforme politique ne sera pas possible sans le suffrage des femmes. Son argument est que les femmes sont les mieux placées pour avancer la réforme politique puisque, pour elle, les femmes sont les protectrices des mœurs de la communauté et qu'elles voteront nécessairement en faveur de la prohibition. En 1893, elle organise un simulacre du parlement avec le support de la Woman's Christian Temperance Union, où elle joue le rôle de première ministre. Elle y invite plusieurs députés dont plusieurs y assisteront. Vers la fin de la séance, deux pétitions en faveur du suffrage des femmes circulent. Ces pétitions recueillent des milliers de signatures.  En 1894, Amelia Yeomens participe à la fondation de la Equal Franchise Association et agit en tant que la première présidente de l'association. Elle sera également présidente régionale de la Woman's Christian Temperance Union de 1896-1897.

Fin de vie
En 1904, elle rejoint sa plus jeune fille Charlotte à Calgary. Elle ne pratique plus la médecine durant cette période, mais demeure active au sein des mouvements pour le suffrage des femmes et la tempérance. Amelia Yeomans meurt le  à Calgary.

Notes et références

Liens externes

Suffragette canadienne
Médecin québécois
Étudiant de l'université d'État du Michigan
Naissance en  mars 1842
Naissance à Québec
Décès à Calgary
Décès en avril 1913
Décès à 71 ans


text:
Q: name attribute self references id In short, is there some self reference code to set the name attribute equal to the id?
for example,
<input name="this.id" id="input1">

In long, using .serialize() requires use of the name attribute. Hypothetically, there is a form that contains many inputs without name attributes. I'm aware of,

*

*how I could (read, "should") add name attributes that match the id's to each input,

*creating a separate function to serialize the form using id attribute,

*similar solution like in this question,

*the steps taken to submit a form.

However, in some research on SO, I was led to believe that if a person were to use,
<input name="id[]" id="input1">

when serialized, the name would have the id appended to it. In my tests this method produces id%5B%5D (url encoded string of id[]). Using anything available, is there a short hand way to set the name attribute so that it references the id attribute on each input?

A: There is nothing in HTML that will do the reference so you will need to set it manually. The best solution, set it when you build the form. Or set it when you reference the elements

console.log($("input").attr("name", function (){ return this.name || this.id }).serialize())
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.1/jquery.min.js"></script>
<input id="foo1" value="1" />
<input id="foo2" value="2" />
<input id="foo3" value="3" />
<input id="foo4" value="4" />

or just write your own method

$.fn.serializeId = function() {
  return $(this).map(function(){
    return this.id + "=" + encodeURIComponent($(this).val())
  }).get().join("&");
}

console.log($("input").serializeId())
<script src="https://ajax.googleapis.com/ajax/libs/jquery/2.1.1/jquery.min.js"></script>
<input id="foo1" value="1" />
<input id="foo2" value="2" />
<input id="foo3" value="3" />
<input id="foo4" value="4" />

redpajama_set_name: RedPajamaStackExchange


1 Locating Affordable Dental Implants in Thornton, Colorado– Why So Expensive?
5 How Do I Get Dental Implants in Thornton CO?
You believed everything was fine. No one appeared to notice that you were missing a couple of teeth, and after that someone crossed the line. You were offered gran slippers as well as a crocheted blanket for Xmas, the tip being that it was time to crinkle up on the couch with your cat and also a glass of cozy milk.
Locating Affordable Dental Implants in Thornton, Colorado– Why So Expensive?
Losing your teeth has begun to make you look old. You barely speak to any individual anymore anyhow, so why not settle in for a very early snooze? Nonsense! When affordable dental implants are simply a phone call away, you don't have to settle.
Possibly relative will be a lot more tactful and direct concerning it, yet a person has to inform you that affordable dental implants can be life-altering. Finding affordable dental implants begins with a net search as well as the desire to travel a bit. Possibilities are you will have to go to a major city to find a dental expert that makes it his organisation to supply budget-friendly oral services to people that need them. It may feel like false economy if you have to spend for train tickets or gas, yet simply keep in mind the distinction in price and it soon ends up being clear: traveling is well worth the initiative to have your smile again.
The reason dental implants are so costly is that whole lots of individuals obtain associated with making them, inserting them and also completing them. Include this to the expense of materials plus the dentist's helicopter costs, and also soon you will certainly need to sell your vehicle to be able to consume steak again.
How Do I Get Dental Implants in Thornton CO?
Dental experts can reduce costs by doing just what every consumer does to conserve cash: getting in bulk. Because there is no such point as a poor dental expert, it is clear that these treatments occur typically enough for a specialist to purchase products in breakthrough. In addition, if he is trained, he could perform even more of the job himself rather than sending you to a various person to deal with each section of the process. All of this might conserve you cash, even after you request a strong sedative to obtain you through the procedure.
A lot of these dental techniques promote solutions online. Net advertising helps to keep prices down and also reach even more individuals, while broadening their client base at the very same time. More customers and also lower media expenses amount to savings we could pass on to consumers. Make certain to request a price analysis for the dental implants when you see one of our dental professionals.
Think about making use of these services prior to any person has to trigger you. Shock them with a new smile. The advantages start with self esteem, which is critical to living a complete life. Not everybody who sheds teeth will certainly be senior. Lots of youngsters deal with dental problems or injuries which bring about missing teeth. When you can not smile or talk freely, this cuts you off from individuals and hampers your possibilities of success, especially if you wish to operate in a customer care capacity.
Even worse still, your jaw needs teeth in it to remain healthy and balanced. Without anything to sustain, your jaw begins to waste away like a muscle that never ever obtains made use of. Your mouth will certainly alter shape to ensure that, even if you want to get dentures ultimately, they will not fit. Act rapidly to prevent this from happening and offer us a call today.
The benefit of picking affordable dental implants over dentures is that they will help you to keep bone mass, whereas dentures do not. You have just as great a possibility of shedding bone if you put on dentures as you do without teeth.
Even dentures can be placed in your mouth semi-permanently. Your dental professional will certainly fix them to a variety of messages to ensure that you take hip jump lessons without shedding them. While the yelling of your other dancers or the audience as they go flying could be exciting, the rule of 'finders caretakers' could spell your failure for locating affordable dental implants.
Pay little focus on the price of your pal's procedure. Her mouth is various from yours, so the solutions you require will not cost the same amount. It might take much longer for your treatment to be ended up. A lot more materials might be needed. Bone grafting could be necessary prior to any type of further job can be done. Attempt not to be demandinged.
When selecting affordable dental implants, simply discover out just what sort of anesthetic solutions are offered at the very same time. This ought to place you at your convenience. You could be asleep the whole time. This is especially useful if your primary worry concerning going to the dental professional is that you are simply afraid. A fear of dental professionals prevails, but is sometimes avoidable. Do not view 'Little Store of Horrors' or 'Marathon Guy,' and you could be just great.
Maybe family members will be extra skillful and direct about it, however somebody needs to inform you that affordable dental implants can be life-altering. Discovering affordable dental implants starts with a net search and also the determination to travel a bit. While the shrieking of your fellow dancers or the target market as they go flying could be amazing, the regulation of 'finders keepers' could mean your downfall for discovering affordable dental implants.


text:
Mathias David Grönberg (Stockholm, 12 maart 1970) is een Zweedse voormalig golfprofessional.

Amateur
Mathias begon pas met golf toen hij vijftien jaar was, maar werd al gauw in het nationale jeugdteam opgenomen. Na drie jaar werd hij nationaal jeugdkampioen.

Gewonnen
 1988: Swedish Boys Championship
 1990: British Youths Open Amateur Championship in Southerness
 1991: Swedish Open

Teams
 Eisenhower Trophy (namens Zweden): 1990 (winnend team en individueel winner)

Professional
Mathias Grönberg werd in 1990 professional.

Europese Tour
Vanaf 1993 speelde Grönberg op de Europese PGA Tour. In zijn debuutjaar eindigde hij op de tweede plaats op het Open op de Hilversumsche Golf Club achter Maarten Lafeber. In 1995 won hij de Canon European Masters in Crans, waardoor hij vijf jaar speelrecht op de Tour kreeg. Dat jaar eindigde hij op de 22ste plaats van de Order of Merit, hetgeen hij in 1998 verbeterde met een 10de plaats o.a. dankzij winst op de European Open. In 1998 werd hij dan ook gekozen voor het de Zweedse teams voor de Alfred Dunhill Cup en de World Cup. Eind 2004 moest Grönberg weer naar de Tourschool. In 2000 was Grönberg de beste op de South African Open en in 2003 won Grönberg de Italiaans Open.

Amerikaanse Tour
Vanaf 2004 speelde Grönberg vooral op de Amerikaanse PGA Tour. Toch moest hij eind 2008 terug naar  Amerikaanse Qualifying School. In 2008 heeft hij een voetblessure en raakt zijn kaart kwijt maar haalde op de Qualifying School weer een kaart voor 2009. Daar behaalde hij in 2009 op de Nationwide Tour (NT) zijn eerste overwinning. Hij eindigde in de top-25 en promoveerde naar de Amerikaanse PGA Tour van 2010. Daarna zou Grönberg vooral uitkomen op de Nationwide Tour.

Overwinningen

Teamdeelnames

 Alfred Dunhill Cup (namens Zweden): 1998, 2000
 World Cup (namens Zweden): 1998, 2000
 Seve Trophy (namens continentaal Europa): 2002

Resultaten op de Majors

CUT = miste de cut halverwege

Resultaten op de World Golf Championships

CUT = miste de cut halverwege

Mathias Grönberg Trophy
Grönberg heeft een Amerikaanse echtgenote, een zoon Van, een dochter Eva en een Amerikaans accent. Toch is hij gevoelsmatig zeer Zweeds. In 2008 organiseert hij de Mathias Grönberg Trophy in Zweden, om golf meer populair te maken bij de jeugd. Hij hoopt dat het een jaarlijks toernooi wordt.

Ze wonen ten zuiden van New York, maar verhuizen in 2008 naar Palm Beach in Florida.

Externe links
  Profiel van Mathias Grönberg op de Europese PGA Tour
  Profiel van Mathias Grönberg op de Challenge Tour
  Profiel van Mathias Grönberg op golfdata.se

  Profiel van Mathias Grönberg op de PGA Tour
  Profiel van Mathias Grönberg op where2golf.com
  Profiel van Mathias Grönberg op golfmajorchampionships.com
 Officiële website

Zweeds golfer


S.E. Sarasin, aka "Broadway", was a Terran Confederation officer assigned to the TCS Tiger's Claw. He was promoted to Lieutenant in in April, 2654, which was reflected in that month's Comm Relay.
This page was last edited on 30 August 2010, at 00:31.


Director check available online for Caroline O Brien, Isle Of Lewis, HS2 0QG.
Director check available online for Caroline O Brien, Liverpool, Merseyside, L15 7LZ.
Caroline Brien, beauty features editor at Marie Claire magazine, recommends the best eye creams with SPF.
Contact information and Free Ratings and Reviews for Doctor Heather Jane Caroline Brien - Oakville, Ontario.
Books by Caroline Brien at OBNB, the Open British National Bibliography.
Comcit. Looking plum & perky without any redness – thank you Sharon! – Caroline Brien – freelance beauty journalist . Such a fantastic treatment!
Caroline Brien. HT (Production Assistant) Yann Laforest. HT ... Latest from the BFI. Latest news, features and opinion. More information. Films, TV and people.
Find out about the Brien surname in Britain, including the meaning, etymology, origin and distribution.


text:
Biohazard, Trauma and Crime Scene Cleanup Services in Lehigh County, PA
Facts About Lehigh County, Pennsylvania
Lehigh County is a county located in the Lehigh Valley region of the U.S. state of Pennsylvania. As of the 2010 census, the population was 349,497. Its county seat is Allentown, the state's third-largest city behind Philadelphia and Pittsburgh. The county, which was first settled around 1730, was formed in 1812 with the division of Northampton County into two counties. It is named after the Lehigh River, whose name is derived from the Delaware Indian term Lechauweki or Lechauwekink, meaning "where there are forks". Lehigh County is part of the New York City metropolitan area, but also borders the Delaware Valley and is a part of the Philadelphia media market. It is one of the fastest-growing counties in Pennsylvania.
According to the U.S. Census Bureau, the county has a total area of 348 square miles (900 km²), of which 345 square miles (890 km²) is land and 3.1 square miles (8.0 km²) (0.9%) is water.
As of the 2010 census, the county was 71.6% White Non-Hispanic, 6.1% Black or African American, 0.4% Native American or Alaskan Native, 2.9% Asian, 0.0% Native Hawaiian, 2.9% were two or more races, and 8.6% were some other race. 18.8% of the population were of Hispanic or Latino ancestry. As of the census of 2000, there were 312,090 people, 121,906 households, and 82,164 families residing in the county. The population density was 900 people per square mile (348/km²). There were 128,910 housing units at an average density of 372 per square mile (144/km²). The racial makeup of the county was 87.02% White, 3.56% Black or African American, 0.18% Native American, 2.10% Asian, 0.04% Pacific Islander, 5.28% from other races, and 1.83% from two or more races. 10.22% of the population were Hispanic or Latino of any race. 27.1% were of German, 7.9% Italian, 7.7% Irish, 6.2% Pennsylvania German and 5.6% American ancestry. 85.0% spoke English, 8.4% Spanish and 1.2% Arabic as their first language.
Catasauqua, PA
Serving Lehigh County, Pennsylvania
Bio-One services all types of trauma, distressed property, and biohazard scenes in communities throughout the Trenton Area. We partner with local authorities, communities, emergency services personnel, victim services groups, hoarding task forces, apartment complexes, insurance companies and others to provide the most efficient and superior service possible.
out of 5 ratings